- Home
- LGND vs ATGE Comparison
LGND vs ATGE Comparison
Compare LGND & ATGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGND
- ATGE
- Stock Information
- Founded
- LGND 1987
- ATGE 1987
- Country
- LGND United States
- ATGE United States
- Employees
- LGND N/A
- ATGE N/A
- Industry
- LGND Biotechnology: Pharmaceutical Preparations
- ATGE Other Consumer Services
- Sector
- LGND Health Care
- ATGE Consumer Discretionary
- Exchange
- LGND Nasdaq
- ATGE Nasdaq
- Market Cap
- LGND 2.3B
- ATGE 2.7B
- IPO Year
- LGND 1992
- ATGE 1991
- Fundamental
- Price
- LGND $111.89
- ATGE $98.27
- Analyst Decision
- LGND Strong Buy
- ATGE Buy
- Analyst Count
- LGND 6
- ATGE 3
- Target Price
- LGND $145.00
- ATGE $91.67
- AVG Volume (30 Days)
- LGND 124.3K
- ATGE 438.4K
- Earning Date
- LGND 02-25-2025
- ATGE 01-30-2025
- Dividend Yield
- LGND N/A
- ATGE N/A
- EPS Growth
- LGND 160.46
- ATGE 88.45
- EPS
- LGND 2.47
- ATGE 4.36
- Revenue
- LGND $152,422,000.00
- ATGE $1,633,207,000.00
- Revenue This Year
- LGND $26.86
- ATGE $10.81
- Revenue Next Year
- LGND $14.95
- ATGE $6.15
- P/E Ratio
- LGND $45.27
- ATGE $22.54
- Revenue Growth
- LGND N/A
- ATGE 11.45
- 52 Week Low
- LGND $67.72
- ATGE $43.78
- 52 Week High
- LGND $129.90
- ATGE $99.17
- Technical
- Relative Strength Index (RSI)
- LGND 50.22
- ATGE 65.98
- Support Level
- LGND $102.79
- ATGE $89.62
- Resistance Level
- LGND $112.61
- ATGE $97.37
- Average True Range (ATR)
- LGND 4.01
- ATGE 2.63
- MACD
- LGND 0.39
- ATGE 0.45
- Stochastic Oscillator
- LGND 87.67
- ATGE 91.15
About LGND Ligand Pharmaceuticals Incorporated
Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.
About ATGE Adtalem Global Education Inc.
Adtalem Global Education Inc is an American for-profit educational company that operates various university and educational programs. The company has three segments namely Chamberlain; Walden; and Medical and Veterinary. It derives maximum revenue from Chamberlain segment.